On January 21, 2021 the White House released the new administration’s National Strategy for the COVID-19 Response and Pandemic Preparedness. While initially it seems to be a daunting 200 page document, it is divided into three manageable sections. First, the core of the recommendations are presented in just twenty pages. If that’s all you have time to read, focus there. The document then expounds on the seven goals and related action plans in the next ninety-five or so pages. Finally, the remainder of the document is a compilation of the new Executive Orders signed by the president that support the plan.
Now that COVID-19 doses administered data are flowing to Immunization Information Systems (IIS), we are noticing some unintended side effects from the data management component of the vaccination program. Here are a few that have bubbled up from the jurisdictions we support:
On November 23, 2020, the Centers for Disease Control and Prevention (CDC) Office of Infectious Disease and HIV/AIDS Policy (OIDP) published a draft Vaccines National Strategic Plan 2021-2025. This is an update of the National Vaccine Plan last published in 2010. This updated draft vaccine plan provides a vision for the nation’s vaccine and immunization enterprise for the next five years and articulates a comprehensive strategy to enhance vaccination in the United States.
There is a global race for the development of a vaccine for the SARS-CoV-2 virus that causes COVID-19. Finding a vaccine that works and receives approval is only part of the process. There are a series of other steps that need to be taken so that the vaccine can be delivered. These include the mass production of the vaccine, shipment, administration and record-keeping. This may be even more complex as there may be several vaccines.
In this article we review some of these issues with a particular focus on the United States.